Eu­ro­pean Com­mis­sion re­jects Ipsen's ul­tra-rare dis­ease drug af­ter two neg­a­tive opin­ions from EMA

The Eu­ro­pean Com­mis­sion has re­ject­ed Ipsen’s po­ten­tial new drug palo­varotene for those with the ul­tra-rare ge­net­ic con­nec­tive tis­sue dis­or­der known as fi­brodys­pla­sia os­si­f­i­cans pro­gres­si­va, or …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER